GB914417A - Novel sulphonamides and a process for their manufacture - Google Patents

Novel sulphonamides and a process for their manufacture

Info

Publication number
GB914417A
GB914417A GB26886/61A GB2688661A GB914417A GB 914417 A GB914417 A GB 914417A GB 26886/61 A GB26886/61 A GB 26886/61A GB 2688661 A GB2688661 A GB 2688661A GB 914417 A GB914417 A GB 914417A
Authority
GB
United Kingdom
Prior art keywords
pyrimidine
lower alkoxy
amino
sulphanilamido
pyrimidines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB26886/61A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of GB914417A publication Critical patent/GB914417A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/34One oxygen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/69Benzenesulfonamido-pyrimidines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention comprises 5-sulphanilamido-6-(lower alkoxy, i.e C1-5 alkoxy)-pyrimidines and pharmaceutically acceptable salts thereof, 5 - (N4-acyl-sulphanilamido)-6-(lower alkoxy)-pyrimidines, and the process for the preparation of the sulphanilamides by condensing a 5-amino-6-(lower alkoxy)-pyrimidine with a benzenesulphonyl halide containing in the para-position a substituent convertible to the amino group by reduction or hydrolysis, e.g. a nitro, alkoxycarbonylamino, benzyloxycarbonylamino or acylamino (such as acetylamino) group, converting the para substituent in the resulting para-substituted-(e.g. p-acylamino-)benzenesulphonamido - pyrimidine to the amino group and, if desired, converting the product into a pharmaceutically acceptable salt, such as an alkali-metal, alkaline-earth metal or organic base (e.g. diethanolamine) salt. Preferred products comprise 5-sulphanilamido-6-methoxy-pyrimidine and its N -acetyl derivative. 5-Amino-6-(lower alkoxy)-pyrimidines such as 5-amino-6-methoxy-pyrimidine are made by reacting 4,6-dichloro-5-nitro-pyrimidine with an alkali-metal alcoholate, reducing the resulting 4-chloro-5-nitro-6-(lower alkoxy)-pyrimidine to 4-chloro-5-amino-6-(lower alkoxy)-pyrimidine and removing the 4-chloroatom by catalytic hydrogenation. Pharmaceutical preparations, having antibacterial activity, comprise the sulphanilamido-pyrimidines of the invention, or salts thereof, in admixture with a solid or liquid, organic or inorganic carrier suitable for enteral (e.g. oral) or parenteral administration. The preparations suitably take the form of tablets, dragees, suppositories, capsules, solutions, emulsions or suspensions and may contain, in addition to usual excipients, preserving, stabilizing, wetting or emulsifying agents, salts for varying osmotic pressure or buffers.
GB26886/61A 1960-08-09 1961-07-25 Novel sulphonamides and a process for their manufacture Expired GB914417A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH899560 1960-08-09

Publications (1)

Publication Number Publication Date
GB914417A true GB914417A (en) 1963-01-02

Family

ID=4347166

Family Applications (1)

Application Number Title Priority Date Filing Date
GB26886/61A Expired GB914417A (en) 1960-08-09 1961-07-25 Novel sulphonamides and a process for their manufacture

Country Status (5)

Country Link
BE (1) BE606495A (en)
ES (1) ES269656A1 (en)
FR (1) FR1440M (en)
GB (1) GB914417A (en)
NL (1) NL267524A (en)

Also Published As

Publication number Publication date
ES269656A1 (en) 1962-03-16
BE606495A (en) 1962-01-25
NL267524A (en)
FR1440M (en) 1962-08-13

Similar Documents

Publication Publication Date Title
GB1464326A (en) Benzimidazole carbamates
ES378247A1 (en) Hydroquinoline thiocarbamic acid derivatives
GB914417A (en) Novel sulphonamides and a process for their manufacture
GB1363047A (en) Pyrimidine derivative process for its preparation and its use as a medicament
GB1350878A (en) Coumarin derivatives and production thereof
GB1319772A (en) Succinimides
ES269442A1 (en) Lysine orotate
ES273933A1 (en) Pyrimethamine salt with 2, 6-dihydroxyisonicotinic acid
GB946485A (en) Novel sulphonamides and a process for the manufacture thereof
ES264827A1 (en) Novel sulphonamides and a process for the manufacture thereof
GB1417776A (en) Pharmaceutical compositions
GB1364521A (en) Aminoglycoside antibiotics
GB557447A (en) Pharmaceutical composition comprising mixtures and/or reaction products of sulphonamide compounds and bile derivatives
GB914929A (en) Novel sulphonamides and a process for the manufacture thereof
GB1199758A (en) Arylsulphonyl-Semicarbazides and their production
GB1360032A (en) 2-thio-5-azocytosine and its nucleosides
GB1132424A (en) New n'-substituted n-arylsulphonyl urea preparations and compositions containing same
GB895625A (en) New benzene-sulphonyl benzyl-ureas and process of preparing them
GB858133A (en) Manufacture of metal salts of formo-sulphathiazole
GB1262315A (en) New benzenesulphonamide derivatives, their production ond compositions containing same
GB1269832A (en) TRICYCLO(4.4.0.0<3.8>)DECAN-1-AMINE AND alpha-METHYLTRICYCLO(4.4.0.0<3.8>)DECAN-1-METHYLAMINE AND PROCESS FOR PREPARING SAME
GB982707A (en) New sulphonamides and process for preparing same
GB1249538A (en) Adenosine derivatives
GB922049A (en) New sulphonamide and process for its manufacture
GB1217135A (en) Daunomycin derivatives